Navigation Links
Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Date:1/17/2011

Ebersberg, Germany, January 17, 2011 Eurofins MWG Operon, international market leader and expert for DNA sequencing, has signed a 2-year contract to supply DNA sequencing services to the Research Councils UK Shared Services Ltd (RCUK SSC Ltd). The contract may be extended to 3 years, and builds on a 5-year relationship developed as a preferred supplier of synthetic DNA and RNA oligonucleotides to the Research Councils.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. The shared service approach reduces costs whilst raising operational efficiency for the Councils.

"We are pleased to have the opportunity to further develop our relationship with RCUK. This contract will allow us to demonstrate our competence and strength in genomic services beyond the provision of synthetic DNA and RNA oligonucleotides", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "The synergies across our service offerings allow us to optimize our client service, from ordering convenience, to streamlined processes, through to faster turnaround time."

Richard Fowles, Category Manager at RCUK SSC Ltd commented, "RCUK SSC Ltd is pleased to announce the selection of Eurofins as one of its preferred suppliers of DNA sequencing services. Eurofins is already a proven supplier of oligos and we believe this new contract will afford them opportunities to further enhance their already strong reputation."

Eurofins MWG Operon also provides best in class next generation sequencing services, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
2. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. Eurofins MWG Operon and Genomatix launch strategic alliance
5. Verizon Business to Provide Global IP for Eurofins Scientific
6. Reading the signs: Plants and animals found common ground in response to microbial threats
7. China PharmaHub Signs Distribution Agreement with Integrated Biometrics
8. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
9. Speed installation of system to monitor vital signs of global ocean, scientists urge
10. SailPoint Signs International Reseller Agreement with BMC Software
11. Road signs and traffic signals on DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... YORK , March 28, 2017 ... highly volatile and unpredictable sector due to the ... Markets served include medical, agricultural, environmental, and industrial. In ... four stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience ... and Ocular Therapeutix Inc. (NASDAQ: OCUL ...
(Date:3/28/2017)... Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or ... data from its phase 1/2 tendon repair study investigating the ... as a treatment for Achilles tendinosis. ... The clinical trial met ... months and showed no serious adverse events related to the ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Harvill as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished ... and operations. , Avomeen is a leader in a wide range of ...
(Date:3/27/2017)... ... 27, 2017 , ... IsoPlexis Corporation (IsoPlexis), a venture capital-funded ... more through a single-cell precision engineering platform, today announced it has received an ... the laboratory of Dr. James Heath at the California Institute of Technology, a ...
Breaking Biology Technology: